Advertisement
Baxter's leadership position resulted from best scores across a number ofperformance areas including bioethics, codes of conduct, environmentalperformance and policy/management, talent attraction and retention, and socialand environmental reporting.
Advertisement
"We're proud to be recognized again for our commitment to a range ofactivities that help ensure a sustainable world," said Robert L. Parkinson,Jr., Baxter's chairman and chief executive officer. "As a global corporation,we believe that we have a responsibility to balance society's current andfuture needs with the goals of the business."
The Dow Jones Sustainability indices, derived from the Dow Jones GlobalIndex, are the world's first benchmarks tracking the financial performance ofleading sustainability-driven companies worldwide. The DJSI World Index tracksthe financial performance of the top 10 percent of the 2,500 largest companiesin the Dow Jones Global Index in terms of social, economic and environmentalperformance. The DJSI North America Index includes the top 20 percent in eachof 57 sectors out of the largest 600 North American companies in the Dow JonesGlobal Index.
In addition to Baxter's inclusion in the DJSI, the company has beenrecognized by Innovest Strategic Value Advisors as one of the Global 100 MostSustainable Corporations in the World, by Corporate Responsibility Officermagazine as one of the 100 Best Corporate Citizens in the United States and byEthisphere magazine as one of the World's Most Ethical Companies. Baxter is amember of the Center for Corporate Citizenship at Boston College, the BusinessEnvironmental Leadership Council of the Pew Center on Global Climate Exchange,the Chicago Climate Exchange, the U.S. EPA's Climate Leaders, the Ethics &Compliance Officer Association and Hospitals for a Healthy Environment. Baxterendorses the Ceres principles and is an organizational stakeholder of theGlobal Reporting Initiative.
Baxter International Inc., through its subsidiaries, assists healthcareprofessionals and their patients with the treatment of complex medicalconditions, including hemophilia, immune disorders, cancer, infectiousdiseases, kidney disease, trauma and other conditions. The company applies itsexpertise in medical devices, pharmaceuticals and biotechnology to make ameaningful difference in patients' lives.
SOURCE Baxter International Inc.
